Hungarian pharma firm grabs assets in Brazil, Mexico

Hungarian pharmaceutical firm Gedeon Richter is growing its footprint in Latin America with two acquisitions. The firm agreed to buy a 51% stake in Brazilian importer and distributor Next Pharma last month. It also agreed to buy 70% of Mexican firm DNA Pharmaceuticals, and to increase that to 100% over the next three years. The acquisitions are part of a diversification play into a region with one of the world’s fastest growing pharmaceutical markets, the company’s managing director said. The sale prices were not disclosed.